IRONWOOD INVESTMENT MANAGEMENT LLC
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 1127761
BOSTON, MA
Position in AUPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,924,177
+$248,539 QoQ
Shares Held
113,387
+0.3% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#73
of 279 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IRONWOOD INVESTMENT MANAGEMENT LLC holds $13,113,875 across 6 Biotechnology names. AUPH ranks #3 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
56,589 | $4,820,816 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
61,163 | $4,555,420 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
This page
|
113,387 | $1,924,177 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
52,080 | $1,339,497 | |
| 5 | REPL |
Replimune Group, Inc.
|
21,525 | $238,281 | |
| 6 | VALN |
Valneva SE
|
45,064 | $235,684 |
All Filings in AUPH
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,924,177 | 113,387 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,675,638 | 113,066 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,828,189 | 114,620 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,269,180 | 114,858 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $981,376 | 115,865 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $945,857 | 117,644 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $846,903 | 94,310 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $683,016 | 93,181 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $513,112 | 89,862 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $466,826 | 93,179 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $857,187 | 95,349 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $745,842 | 95,990 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $953,063 | 98,457 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,092,679 | 99,697 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $404,602 | 93,658 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $979,931 | 130,310 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,338,207 | 133,155 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,647,988 | 133,117 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,013,351 | 131,760 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,715,383 | 167,889 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,181,401 | 168,318 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,211,553 | 170,316 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,978,768 | 143,078 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,144,688 | 145,600 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,368,925 | 145,780 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $2,128,573 | 146,697 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||